Arthritis advocates urge Congress to take action to address drug costs, access issues
(PHYSorg.com Medicine & Health)

Physician and healthcare professional advocates from the American College of Rheumatology (ACR) are joined by rheumatology patients on Capitol Hill this week to urge lawmakers to address the significant drug cost and access issues affecting millions of Americans living with arthritis and other rheumatologic diseases. More than 100 advocates met with Congressional and Senate leaders and staff today to advocate for meaningful legislative reforms that would lower biologic drug costs and make life-changing therapies and treatments more accessible to the 54 million Americans living with rheumatic diseases.